Liquid Dosage Forms: Solutions, Suspensions, and Emulsions

Liquid dosage forms offer advantages in patients who cannot swallow solid dosage forms — paediatric, geriatric, and dysphagia populations. They provide rapid absorption (solutions), dose flexibility, and ease of administration. However, they present unique formulation challenges: physical and chemical instability, microbial contamination risk, bulkiness, and palatability.

Solutions are homogeneous, single-phase systems in which the drug is fully dissolved. Solubility enhancement strategies are central to solution formulation. Co-solvents (ethanol, propylene glycol, PEG 400, glycerol) reduce polarity of the aqueous medium. Surfactants (polysorbates, Cremophor EL) form micelles that solubilise hydrophobic drugs via the micellar interior. Complexation with cyclodextrins (hydroxypropyl-β-cyclodextrin, HP-β-CD) forms inclusion complexes that dramatically increase apparent aqueous solubility. pH adjustment shifts ionisable APIs to their more soluble ionic form — salt selection is critical (pKa ± 2 units from formulation pH maximises solubility).

Oral solutions require flavouring agents for palatability, buffering agents to maintain pH, and preservatives. Common preservatives include sodium benzoate (active below pH 4.5, as the non-ionised benzoic acid is the active antimicrobial species), methyl and propyl parabens (broad spectrum, estrogenic concern limits paediatric use), sorbic acid, and benzalkonium chloride (more common in topicals). Preservative efficacy testing (PET, Ph. Eur. 5.1.3) must demonstrate adequate antimicrobial activity across the product's microbial challenge spectrum.

Suspensions are two-phase systems with insoluble drug particles dispersed in a continuous phase. Physical stability of suspensions is governed by Stokes' Law: settling velocity v = 2r²(ρₚ - ρₘ)g / 9η, where r is particle radius, ρₚ and ρₘ are particle and medium density, g is gravitational acceleration, and η is medium viscosity. Strategies to retard sedimentation include particle size reduction (micronisation), viscosity enhancement (xanthan gum, HPMC, carbomers), and density matching between particle and medium.

Flocculation control is critical. Deflocculated (peptised) suspensions produce a compact, difficult-to-redisperse sediment (caking). Flocculated suspensions settle rapidly but redisperse easily with gentle shaking. Controlled flocculation using electrolytes (exploiting the zeta potential minimum) or polymeric bridging agents achieves a loosely structured sediment. Zeta potential measurement (stable colloidal dispersions typically >±30 mV) guides formulation.

Wetting agents facilitate penetration of aqueous medium into hydrophobic drug particles. Sodium lauryl sulphate, polysorbate 80, and lecithin reduce interfacial tension at the solid-liquid interface. Without adequate wetting, hydrophobic particles float or agglomerate rather than dispersing uniformly.

Emulsions are thermodynamically unstable two-phase systems of immiscible liquids stabilised by an emulsifying agent. Oil-in-water (O/W) emulsions have an aqueous continuous phase; water-in-oil (W/O) emulsions have an oily continuous phase. HLB (hydrophile-lipophile balance) value of the emulsifier determines preference — HLB 3–8 favours W/O; HLB 8–18 favours O/W. Primary emulsifiers (Tween, Span, lecithin, acacia) adsorb at the oil-water interface and reduce interfacial tension; secondary emulsifiers (HPMC, tragacanth) increase viscosity of the continuous phase.

Emulsion instability manifests as creaming (density-driven phase separation without droplet coalescence, reversible), flocculation (droplet aggregation without coalescence), coalescence (irreversible droplet fusion), Ostwald ripening (larger droplet growth at expense of smaller), and phase inversion (O/W converting to W/O). Long-term stability is assessed by centrifugation (3750 rpm, 5h ≈ 1 year ambient), elevated temperature cycling, and freeze-thaw studies.

Chemical stability considerations include hydrolysis (esters, amides, lactams — pH-rate profiles guide optimum pH selection), oxidation (antioxidants: ascorbic acid, sodium metabisulphite, BHT, BHA — purge with nitrogen), and photodegradation (amber containers, photoprotective packaging). Accelerated stability studies at 40°C/75% RH per ICH Q1A(R2) predict shelf life via Arrhenius equation.